Journal of Vascular Surgery
Volume 35, Issue 3 , Pages 554-562 , March 2002

Pathologic and histologic results of electrical impulses in a rabbit model of atherosclerosis: 24-hour versus 8-hour regimen

Received 30 April 2001 ,Accepted 31 October 2001.

References 

  1. Murray CJL, Lopes AD. The global burden of disease. In: Boston: Harvard School of Public Health/Harvard University Press; 1996;p. 1–34
  2. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801–809
  3. Van der Wal AC, Becker AE. Atherosclerosis plaque rupture: pathologic basis of plaque stability and instability. Cardiovasc Res. 1999;41:334–344
  4. Rekhter MD. Collagen synthesis in atherosclerosis: too much and not enough. Cardiovasc Res. 1999;41:376–384
  5. Roth M, Eickelberg O, Kjohler E, Erne P, Block LH. Ca channel blockers modulate metabolism of collagens within the extracellular matrix. Proc Natl Acad Sci U S A. 1996;93:5478–5482
  6. Bannazoug Y, Logeart D, Labat-Robert L, Jezenfonvicz J, Kern P. Derivatized dextrans modulate collagen synthesis in aortic smooth muscle cells. Biochem Pharmacol. 1995;49:847–853
  7. Fukuyama J, Mizayawa K, Hamano S, Ujie A. Inhibitory effects of tranilast on proliferation, migration, and collagen synthesis of human vascular smooth muscle cells. Can J Physiol Pharmacol. 1989;74:80–84
  8. Perr HA, Drucker DE, Cochran DL, Diegelmann RF, Lindblad WJ, Graham MF. Protamine selectively inhibits collagen synthesis by human intestinal smooth muscle cells and other mesenchymal cells. J Cell Physiol. 1989;140:463–470
  9. Nagler A, Miao HQ, Aingorn H, Pines M, Genina O, Vladavsky I. Inhibition of collagen synthesis, smooth muscle cell proliferation, and injury-induced intimal hyperplasia by halofuginone. Arterioscler Thromb Vasc Biol. 1997;17:194–202
  10. McCaffrey TA, Pomerantz KB, Sanborn TA, Spokojny AM, Du B, Park MH, et al.  Specific inhibition of elF-5A and collagen hydroxylation by a single agent. Antiproliferative and fibrosuppressive effects on smooth muscle cells from human coronary arteries. J Clin Invest. 1995;95:446–455
  11. Chekanov V, Tchekanov G, Maternowski M, Mortada ME, Eisenstein R. Use of electrical stimulation to prevent atherosclerosis in the abdominal aorta: experimental study [abstract]. J Am Coll Cardiol. 2000;35(suppl A):1022
  12. Chekanov V, Maternowski M, Tchekanov G, Mortada ME, Eisenstein R. A new alternative for the use of electrical stimulation: atherosclerosis prevention [abstract]. J Basic Applied Myology. 2000;10:62–63
  13. Anitschkow N. Experimental atherosclerosis in animals. In:  Cowdry EV editors. Atherosclerosis. New York: Macmillan; 1993;p. 271–322
  14. Cornhill JF, Roach MK. A quantitative study of the localization of atherosclerotic lesions in the rabbit aorta. Atherosclerosis. 1976;23:489–501
  15. Roach MR, Cornhill JF, Fletcher J. A quantitative study of the development of sudanophile lesions in the aorta of rabbits fed a lowcholesterol diet for up to six months. Atherosclerosis. 1978;29:259–264
  16. Zeindler CM, Kratky RG, Roach MR. Quantities measurements of early atherosclerotic lesions on rabbit aortae from vascular casts. Atherosclerosis. 1989;75:245–255
  17. Kratky RG, Ivey J, Rogers KA, Daley S, Roach MR. The distribution of fibro-fatty atherosclerotic lesions in the aortae of casein and cholesterol fed rabbits. Atherosclerosis. 1993;99:121–131
  18. Daley SJ, Herderick EE, Cornhill JF, Rogers KA. Cholesterol-fed and casein fed rabbit models of atherosclerosis, part 1: differing lesion area and volume despite equal plasma cholesterol levels. Arterioscler Thromb. 1994;14:95–104
  19. Ivey J, Roach MR, Kratky RGH. A new probability mapping method to describe the development of atherosclerotic lesions in cholesterol fed rabbits. Atherosclerosis. 1995;115:73–84
  20. Forster BA, Javed Q, Leake DS, Weinberg PD. High-resolution mapping of the frequency of lipid deposits in thoracic aortae from cholesterol-fed and heritable hyperlipidemic rabbits. Atherosclerosis. 1996;120:249–253
  21. Sinsinger H, Silberbauer K, Auerswald W. Quantitative investigation of sudenophilic lesions around the aortic ostia of human fetuses, newborns and children. Blood Vessels. 1980;17:44–52
  22. Caro CG, Fitz-Gerald JM, Schroter RM. Atheroma and arterial wall shear: observation correlation and proposal of a shear dependent mass transfer mechanism for atherodenesis. Proc R Soc Lond B. 1971;177:109–159
  23. Svindland A, Walloe L. Distribution pattern for sudanophilic plaques in the descending thoracic and proximal abdominal aorta. Atherosclerosis. 1985;57:219–222
  24. Cornhill JF, Herderick EE, Stary HC. Topography of human aortic sudanophilic lesions. In:  Leipsch DW editors. Blood flow in large arteries: application to atherogeneisis and clinical medicine. Basel, Swizerland;: S Karger; 1990;p. 13–19
  25. Chekanov V, Maternowski M, Eisenstein R, Hernandez I, Nikolaychik VV. Angiogenesis in the latissimus dorsi muscle using different regimens of electrical stimulation and pharmaceutical support. ASAIO J. 2000;46:305–312
  26. Chekanov VS, Rieder MA, Tchekanov GV, Smith LM, Eisenstein R, Schmidt DH. Comparison of different regimens of electrical stimulation applied to nonmobilized and newly mobilized latissimus dorsi muscle. J Card Surg. 1997;12:343–353
  27. Ferrara N. Vascular endothelial growth factor. Trend Cardiovasc Med. 1993;3:244–250
  28. Folkman J. Clinical application of research on angiogenesis. N Engl J Med. 1995;337:1757–1763
  29. Annex B, Torgan CE, Lin P, Taylor DA, Thompson MA, Peters KG, et al.  Induction and maintenance of increased VEGF protein by chronic motor nerve stimulation in skeletal muscle. Am J Physiol. 1998;274:H860–H867
  30. Hang J, Kong L, Gu JW, Adair TH. VEGF gene expression is upregulated in electrically stimulated rat skeletal muscle. Am J Physiol. 1995;269:H1827–H1831
  31. Silverstein RL, Nachman RL. Angiogenesis and atherosclerosis. The mandate broadens. Circulation. 1999;100:783–785
  32. Moulton KS, Heller E, Konerding MA, Flynn E, Palinski W, Folkman J. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apoliprotein E-deficient mice. Circulation. 1999;99:1726–1732
  33. Zhou M, Chen Y, Ougang Q, Liu SX, Pang ZJ. Reduction of the oxidative injury to the rabbits with atherosclerosis by protein bound polysaccharide from coriolus vesicolor. Am J Clin Med. 2000;28:239–249
  34. Ritterhaus CW, Miller DP, Thomas LJ, Witzenbichler B, Yang J, Magner M, et al.  Vaccine-induced antibodies inhibit CETP activity in vivo and reduce aortic lesions in a rabbit model of atherosclerosis. Arterioscler Thromb Vasc Biol. 2000;20:2106–2112
  35. Arruzabala ML, Noa M, Menendez R, Mas R, Carbajal D, Valdes S, et al.  Protective effect of policosanol on atherosclerotic lesions in rabbits with exogenous hypercholesterolemia. Braz J Med Biol Res. 2000;33:835–840
  36. Greenstein SM, Sun S, Calderon TM, Kim DY, Schreiber TC, Schechner RS, et al.  Mycophenolate mofetil treatment reduces atherosclerosis in the cholesterol fed rabbit. J Surg Res. 2000;91:123–129
  37. Wang B, Ho HK, Lin PS, Schwarzacher SP, Pollman MJ, Gibbons GH, et al.  Regression of atherosclerosis: role of nitric oxide and apoptosis. Circulation. 1999;99:1236–1241
  38. Diaz M, Frei B, Vita J, et al.  Antioxidants and atherosclerotic heart disease. N Engl J Med. 1997;337:408–416
  39. Smith C, Mitchinson M, Arnoma O, et al.  Stimulation of lipid peroxidation and hyroxyl-radical generation by the contents of human atherosclerotic lesions. Biochem J. 1992;286:901–905
  40. Lee T, Shiao M, Pan C, et al.  Iron-deficient diet reduces atherosclerotic lesions in apo E-deficient mice. Circulation. 1999;99:1222–1229
  41. Halliwell B. Use of sesferrioxamine as a “probe” for iron-dependent formation of hydroxyl radicals. Biochem Pharmacol. 1985;34:229–233
  42. Duffy S, Biegelsen E, Holbrook M, et al.  Iron chelation improves endothelial function in patients with coronary artery disease. Circulation. 2001;103:2799–2804
  43. Cooper E. Nitric oxide and iron proteins. Biochem Biophys Aeta. 1999;1411:290–309
  44. Biemond P, Swaak A, Beindorff C, et al.  Superoxide-dependent and independent mechanisms of iron mobilization from ferritin by xanthine oxidase. Biochem J. 1986;239:169–173
  45. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340:115–126

☆ Competition of interest: Dr Chekanov holds a patent (#6.201.991) entitled “Method of prevention and treatment of atherosclerosis and article of manufacture thereof.”

☆☆ Reprint requests: Valeri S. Chekanov, MD, PhD, 945 N. 12th St, Rm W419, PO Box 342, Milwaukee, WI 53201-0342 (e-mail: ahcvch@execpc.com ).

PII: S0741-5214(02)62242-6

doi: 10.1067/mva.2002.121756

Journal of Vascular Surgery
Volume 35, Issue 3 , Pages 554-562 , March 2002

Article Tools

* Image Usage & Resolution